CANF vs CGEN: Side-by-Side Comparison
Compare Can-Fite Biopharma Ltd (CANF) and Compugen Ltd (CGEN) side by side: market cap USD 5.12M vs USD 215.58M. Financials, growth and model signals on Bullrun.
| Metric | CANF | CGEN |
|---|---|---|
| Company | Can-Fite Biopharma Ltd | Compugen Ltd |
| Country / Exchange | Israel · NYSE MKT | Israel · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 5.12M | USD 215.58M |
| P/E ratio | — | 6.2 |
| Dividend yield | — | — |
| Valuation model | — | 101.6% undervalued |
| Revenue (FY2025) | USD 405.00K | USD 72.76M |
| Revenue growth YoY | -39.9% | +161.1% |
| Net income | USD -9.83M | USD 35.34M |
| Gross margin | — | 87.3% |
| Diluted EPS | -5.97 | 0.38 |